InVitria
Pre-clinicalInVitria is a global leader in chemically defined, recombinant HSA & cell culture supplements that support the approval of life-changing medicines.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $25M
About
InVitria is a global leader in chemically defined, recombinant HSA & cell culture supplements that support the approval of life-changing medicines.
BiologicsCell Therapy
Funding History
2Total raised:$25M
Series B$15MJun 15, 2018
Series A$10MJun 15, 2015